A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical protocol has 167 procedures with 11 trial visits over 175 days. In addition, oncology trials often have significant delays, with Phase II trials reporting a delay of over 5 months and Phase III trials reporting an almost 6 and a half month delay. In this final episode of a 3-part series, Senior Patient Recruitment Managers Tricia Buchheit and Lauren Johnson consider how rising costs and complex trial designs effect patient recruitment in oncology trials.
Oncology & Hematology Fact Sheet
As a recognized leader in conducting complex, global oncology/hematology trials, PRA has contributed to the approval of 16 important drugs. During…
The Challenges of Patient Recruitment in Oncology Trials - Part 1
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…
Our in-house oncology and hematology experts make the complex, simple. Our